前列腺素E1联合血浆置换治疗慢性重型肝炎的临床研究

Objective To investigate the curative effect, timing and feasibility of prostaglandin E1 combined plasma exchange in treatment of chronic severe hepatitis. Methods Eighty-eight patients with chronic severe hepatitis were randomly divided into treatment group and control group. The treatment group was given prostaglandin E1 combined plasma exchange treatment based on the comprehensive treatment of internal medicine. Control group only had given the internal medicine comprehensive treatment. Results The symptoms and signs of the treatment group were improved after treatments, especially with total bilirubin, cholinesterase, prothrombin activity, NH3 ( P ＜ 0.01,P ＜ 0.05 ). After treatment, except for albumin, the others indicators of the two groups had significant difference ( P ＜ 0.05). Follow-up for three months, the total effective rate of the treatment group was 69.6% ( 32cases ), early effective rate was 79.3% (23 cases), mid-term effective rate was 64.3% (9 cases) were all significantly higher than those of control group [47.6% (20 cases), 55.6% ( 15 cases), 38.5% (5 cases)] (P ＜ 0. 01 ).Conclusion Prostaglandin E1 combined with plasma exchange in treatment of chronic severe hepatitis can improve the liver function and survival rate significantly.     

前列腺素E1联合血浆置换治疗慢性重型肝炎的临床研究

目的 探讨前列腺素E1联合血浆置换治疗慢性重型肝炎的疗效.方法 将88例慢性重型肝炎患者完全随机分为治疗组与对照组.治疗组46例,在内科综合治疗的基础上予前列腺素E1联合血浆置换治疗;对照组42例,只予内科综合治疗.观察2组治疗前后的症状体征及相关实验室指标.结果 治疗组经治疗后症状体征均明显好转,总胆红素、ALT、总蛋白、白蛋白、胆碱酯酶、凝血酶原活动度、血氨均改善明显(P＜0.01或P＜0.05).治疗后,2组间除白蛋白水平外,其余各指标均差异有统计学意义(P＜0.05).随访3个月,治疗组总有效率69.6%(32例)、早期有效率79.3%(23例)、中期有效率64.3%(9例),均明显高于对照组的47.6%(20例)、55.6%(15例)、38.5%(5例),差异均有统计学意义(均P＜0.01).结论 前列腺素E1联合血浆置换治疗慢性重型肝炎能明显改善肝功能,明显提高疗效.

Abstract：

Objective To investigate the curative effect, timing and feasibility of prostaglandin E1 combined plasma exchange in treatment of chronic severe hepatitis. Methods Eighty-eight patients with chronic severe hepatitis were randomly divided into treatment group and control group. The treatment group was given prostaglandin E1 combined plasma exchange treatment based on the comprehensive treatment of internal medicine. Control group only had given the internal medicine comprehensive treatment. Results The symptoms and signs of the treatment group were improved after treatments, especially with total bilirubin, cholinesterase, prothrombin activity, NH3 ( P ＜ 0.01,P ＜ 0.05 ). After treatment, except for albumin, the others indicators of the two groups had significant difference ( P ＜ 0.05). Follow-up for three months, the total effective rate of the treatment group was 69.6% ( 32cases ), early effective rate was 79.3% (23 cases), mid-term effective rate was 64.3% (9 cases) were all significantly higher than those of control group [47.6% (20 cases), 55.6% ( 15 cases), 38.5% (5 cases)] (P ＜ 0. 01 ).Conclusion Prostaglandin E1 combined with plasma exchange in treatment of chronic severe hepatitis can improve the liver function and survival rate significantly.     

纤溶酶联合血塞通注射液治疗急性脑梗死临床研究

Objective To explore the total curative effects of Xuesaitong injection combined whth fibrinogenase on acute cerebral infarction(ACI). Methods One hundred and twelve patients with ACI were randomly and equally divided into two groups, 56 cases in the treatment group were treated with Xuesaitong injection combined Fibrinogenase, while 56 cases in the control group were treated with compound danshen injection, once a day for 15days. Results Coagulation indicators of the treatment group was obviously better than that of the control group(P ＜0.05 or P ＜ 0.01 ). The total effective rate (91.1% ) of the treatment group was obviously higher than that of the control group( 69.6% )( P＜ 0.05 ). The Neurological deficit scores of therapy group were significantly improved (P ＜ 0.05). There was no obvious adverse reaction. Conclusion Xuesaitong injection combined fibrinogenase are remarkablyeffective and safe in treating ACI.     

纤溶酶联合血塞通注射液治疗急性脑梗死临床研究

Objective To explore the total curative effects of Xuesaitong injection combined whth fibrinogenase on acute cerebral infarction(ACI). Methods One hundred and twelve patients with ACI were randomly and equally divided into two groups, 56 cases in the treatment group were treated with Xuesaitong injection combined Fibrinogenase, while 56 cases in the control group were treated with compound danshen injection, once a day for 15days. Results Coagulation indicators of the treatment group was obviously better than that of the control group(P ＜0.05 or P ＜ 0.01 ). The total effective rate (91.1% ) of the treatment group was obviously higher than that of the control group( 69.6% )( P＜ 0.05 ). The Neurological deficit scores of therapy group were significantly improved (P ＜ 0.05). There was no obvious adverse reaction. Conclusion Xuesaitong injection combined fibrinogenase are remarkablyeffective and safe in treating ACI.     

中药外治法用于盆腔炎性疾病后遗症的疗效探讨

Objective To explore the curative effect of treating sequelae of pelvic inflammatory disease with chinese medicine external therapy.Metbods 178 cases that diagnosed as sequelae of pelvic inflammatory disease were randomly divided into control group,test Group 1,and test Group 2.Control group were treated by with broad-spectrum antibioticos for three cycles cycles intravenously;and applying Chinese medicine retention enema and Chinese medicine abdominal hot compress on test Group 1 for three cycles;test Group 2 was used the same methods as group 1 for six cycles.Comparing the comprehensive effect,cure rate and the recurrence rate within the six-month after the treatment.Results Comparing the integrated effect of the three groups;test groups 2 was the optimal(P＜0.01).The cure rates of control group,test Group 1,and test Group 2 were19%34%61%respective;and the recurrence rates were 55%,35%,12%respectively.There were statistically significant differences among these three groups(P＜0.01);test group 2 had the highest cure rate and the lowest recurrence rate;and control group had the opposite results.Conchusion Applying Chinese medicine retention enema and abdominal Chinese medicine hot compress on sequelae of pelvic inflammatory disease for 6 cycles has remarkable treatment effect.     

中药外治法用于盆腔炎性疾病后遗症的疗效探讨

Objective To explore the curative effect of treating sequelae of pelvic inflammatory disease with chinese medicine external therapy.Metbods 178 cases that diagnosed as sequelae of pelvic inflammatory disease were randomly divided into control group,test Group 1,and test Group 2.Control group were treated by with broad-spectrum antibioticos for three cycles cycles intravenously;and applying Chinese medicine retention enema and Chinese medicine abdominal hot compress on test Group 1 for three cycles;test Group 2 was used the same methods as group 1 for six cycles.Comparing the comprehensive effect,cure rate and the recurrence rate within the six-month after the treatment.Results Comparing the integrated effect of the three groups;test groups 2 was the optimal(P＜0.01).The cure rates of control group,test Group 1,and test Group 2 were19%34%61%respective;and the recurrence rates were 55%,35%,12%respectively.There were statistically significant differences among these three groups(P＜0.01);test group 2 had the highest cure rate and the lowest recurrence rate;and control group had the opposite results.Conchusion Applying Chinese medicine retention enema and abdominal Chinese medicine hot compress on sequelae of pelvic inflammatory disease for 6 cycles has remarkable treatment effect.     

中药外治法用于盆腔炎性疾病后遗症的疗效探讨

Objective To explore the curative effect of treating sequelae of pelvic inflammatory disease with chinese medicine external therapy.Metbods 178 cases that diagnosed as sequelae of pelvic inflammatory disease were randomly divided into control group,test Group 1,and test Group 2.Control group were treated by with broad-spectrum antibioticos for three cycles cycles intravenously;and applying Chinese medicine retention enema and Chinese medicine abdominal hot compress on test Group 1 for three cycles;test Group 2 was used the same methods as group 1 for six cycles.Comparing the comprehensive effect,cure rate and the recurrence rate within the six-month after the treatment.Results Comparing the integrated effect of the three groups;test groups 2 was the optimal(P＜0.01).The cure rates of control group,test Group 1,and test Group 2 were19%34%61%respective;and the recurrence rates were 55%,35%,12%respectively.There were statistically significant differences among these three groups(P＜0.01);test group 2 had the highest cure rate and the lowest recurrence rate;and control group had the opposite results.Conchusion Applying Chinese medicine retention enema and abdominal Chinese medicine hot compress on sequelae of pelvic inflammatory disease for 6 cycles has remarkable treatment effect.     

布地奈德联合沙丁胺醇治疗小儿支气管哮喘疗效分析

Objective To investigate the effect of Budesonide combined with Salbutamol in treatment of chil-dren with bronchial asthma.Methods 100 cases of children with asthma were randomly divided into conventional therapy group(Group A)50 cases and combined treatment group(Group B)50 cases;Conventional therapy was given to group B and Group A Was givend the conventional therapy puls Budesonide combined with salbutamol treatment,2 times a day.The course of treatment was 10d;The effect of clinical symptom score、clinical recovery and adverse reac-tions in two groups were observed.Results The total efficiency of 47 cases(94.O%) in group A were significantly higher than the B group 36 cases(72.0%)(P<0.05);The index of breathing diffculties、coushing、wheezing、wheezing sustain and sleep satisfaction after treatment were significantly decreased compared with before treatment in two groups(all P<0.01);The time of recovery of breath shortness、cough、asthma、wheezing and therapy hys in group A were less than group B(all P<0.05).Condusion Atomizing inhalation treatment of Bedesonide combined with Sallbutamol was effective to treat children with bronchial asthma.     

布地奈德联合沙丁胺醇治疗小儿支气管哮喘疗效分析

Objective To investigate the effect of Budesonide combined with Salbutamol in treatment of chil-dren with bronchial asthma.Methods 100 cases of children with asthma were randomly divided into conventional therapy group(Group A)50 cases and combined treatment group(Group B)50 cases;Conventional therapy was given to group B and Group A Was givend the conventional therapy puls Budesonide combined with salbutamol treatment,2 times a day.The course of treatment was 10d;The effect of clinical symptom score、clinical recovery and adverse reac-tions in two groups were observed.Results The total efficiency of 47 cases(94.O%) in group A were significantly higher than the B group 36 cases(72.0%)(P<0.05);The index of breathing diffculties、coushing、wheezing、wheezing sustain and sleep satisfaction after treatment were significantly decreased compared with before treatment in two groups(all P<0.01);The time of recovery of breath shortness、cough、asthma、wheezing and therapy hys in group A were less than group B(all P<0.05).Condusion Atomizing inhalation treatment of Bedesonide combined with Sallbutamol was effective to treat children with bronchial asthma.     

缬沙坦联合贝那普利治疗慢性心力衰竭的疗效观察

Objective To observe the effect of valsartan combined with benazepril in treatment of patients with chronic heart failure. Methods 60 patients with heart failure of New York Heart Association (NYHA) class Ⅱ -Ⅳ and LVEF less than or equal 40% were selected and randomly divided into two groups. The patients in control group were given benazepril(10mg/d) alone,and the patients in treatment group were given valsartan(80mg/d) combined with benazepril(10mg/d). After 8 months therapy, the changes of the parameters of left ventriclular function and ventriclular dimension of the patients with chronic heart failure were compared before and after treatment. And the clinical efficacy was compared between two groups. Results The ventriclular dimension of the patients with chronic heart failure was decreased,and left ventriclular function was improved. The patients of the combination therapy group were improved especially after treatment. Conclusion Angiotensin-converting-enzyme(ACE) inhibitor could improve heart function of patients with chronic heart failure. Therapy of valsartan combined with benazepril was more effective.